“Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration”. 2023. Medinformatics 1 (1): 35-42. https://doi.org/10.47852/bonviewMEDIN32021466.